- B2C
- B2B
- Public StagePublicly traded company
- Top InvestorsThis company has received a significant amount of investment from top investors
Invitae Funding
$0
55 rounds
Invitae is active in the following markets / industries: biotechnology. The company has secured funding across 5 rounds and is valued at $0. Their most recent funding was raised on October 14, 2014.
Funding Rounds
F
$120000000E
$40000000A
$29600000U
$2300000U
$3600000Investors of Invitae
Co-founder and General Partner of Healthy Ventures, early stage infrastructure-first healthcare fund.
THOMAS
Wellington Management
Investment management across global public and private markets
Three Leaf Ventures
Deerfield Capital Management
Perceptive Advisors
Randy Scott
Studied at Texas @Texas A&M University
Thomas, McNerney & Partners
Rounds
F
E
Rock Springs Capital
Rounds
F
Acquisitions of Invitae
Good Start Genetics
Exit
